BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28631441)

  • 1. Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.
    Rosenquist R; Beà S; Du MQ; Nadel B; Pan-Hammarström Q
    J Intern Med; 2017 Nov; 282(5):371-394. PubMed ID: 28631441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
    Bogusz AM; Bagg A
    Leuk Lymphoma; 2016 Sep; 57(9):1991-2013. PubMed ID: 27121112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.
    van den Brand M; Scheijen B; Hess CJ; van Krieken JHJ; Groenen PJTA
    Blood Rev; 2017 Nov; 31(6):426-435. PubMed ID: 28802906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indolent lymphomas of mature B lymphocytes.
    Kurtin PJ
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress on epigenetics of small B-cell lymphoma.
    Ruan X; Zhang R; Zhu H; Ye C; Wang Z; Dong E; Li R; Cheng Z; Peng H
    Clin Transl Oncol; 2022 Aug; 24(8):1501-1514. PubMed ID: 35334078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
    Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
    Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.
    Ghia P; Nadel B; Sander B; Stamatopoulos K; Stevenson FK
    J Intern Med; 2017 Nov; 282(5):395-414. PubMed ID: 28393412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
    Musilova K; Mraz M
    Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [B-cell lymphomas].
    Ennishi D
    Rinsho Ketsueki; 2019; 60(5):434-440. PubMed ID: 31168010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy.
    Dahl M; Kristensen LS; Grønbæk K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic Malignancies Discovered on Investigation of Breast Abnormalities.
    Alsadi A; Lin D; Alnajar H; Brickman A; Martyn C; Gattuso P
    South Med J; 2017 Oct; 110(10):614-620. PubMed ID: 28973700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 expression in B-cell lymphomas.
    Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
    Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphoma.
    Masir N; Jones M; Lee AM; Goff LK; Clear AJ; Lister A; Marafioti T; Mason DY
    Histopathology; 2010 Apr; 56(5):617-26. PubMed ID: 20459572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.
    Callet-Bauchu E; Baseggio L; Felman P; Traverse-Glehen A; Berger F; Morel D; Gazzo S; Poncet C; Thieblemont C; Coiffier B; Magaud JP; Salles G
    Leukemia; 2005 Oct; 19(10):1818-23. PubMed ID: 16094418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.
    Bench AJ; Erber WN; Follows GA; Scott MA
    Int J Lab Hematol; 2007 Aug; 29(4):229-60. PubMed ID: 17617076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of B-cell lymphomas: diagnosis and biomarker discovery.
    Ondrejka SL; Hsi ED
    Cancer Treat Res; 2015; 165():27-50. PubMed ID: 25655605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.